China Biologic's ex-CEO throws his hat in the ring

Former chief of the Nasdaq-listed biotechnlogy firm launches a $3.9 billion bid to take it private. His consortium of backers face a potential battle to bring back ownership to China.

China Biologic's ex-CEO throws his hat in the ring

A consortium led by former boss David Gao has filed an all-cash $3.9 billion offer for Nasdaq-listed China Biologic Products, topping an existing bid by Citic Capital Holdings  as the battle to take the plasma treatment provider private heats up anew. 

Former chief executive and chairman Gao, who led the company for six years before stepping down after Citic's  $3.6 billion  offer in June, is backed by...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Click for more on: china | healthcare | acquisitions | china biologic

Print Edition

FinanceAsia Print Edition